India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
EPS at Rs 32.19
Substantial reduction in losses
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
PAT rises to Rs 195.76 crore
Forex gains stood at Rs 20 crore for the quarter
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
These media reports are based on incorrect facts and are without any basis.
Subscribe To Our Newsletter & Stay Updated
